Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and COVID-19: Demonstrating the Actionability of Real-World Evidence is a research paper published in American Journal of Hypertension (2020). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: K23HL133843
National Institutes of Health
Grant: R01HL153646
National Institutes of Health
Grant: R01AG025152
National Institutes of Health
Grant: R01AG064589
National Institutes of Health
Grant: R01DA048001
National Institutes of Health
Grant: R01AG060975
National Institutes of Health
Grant: 5R01AG064589-03
Enhancing the Utility of the Trend-in-Trend Research Design
National Institutes of Health
Grant: 5R01HL153646-04
Blockade of calcium channels and beta adrenergic receptors for physiologic abnormalities in heart failure with preserved ejection fraction (BLOCK HFpEF)
National Institutes of Health
Grant: 5R01DA048001-04
Drug-Drug Interactions Involving Methadone and Buprenorphine
National Institutes of Health
Grant: 5R01AG060975-02
Drug interactions involving psychoactive drugs
National Institutes of Health
Grant: 1K23HL133843-01
Management of hypertension in obesity: Antihypertensive class effects, blood pressure control, and renal and cardiac outcomes
National Institutes of Health
Grant: 5R01AG025152-13
Clinical Importance of Drug-Drug Interactions
FWCI
0.10
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords